Viewing data from:

TAMSULOSIN HYDROCHLORIDE

ANDA

TAMSULOSIN HYDROCHLORIDE | A204645 | MACLEODS PHARMACEUTICALS LTD

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.0495

per ea

Lowest NADAC/Unit

$0.0495

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
33342015911TAMSULOSIN HCL 0.4 MG CAPSULE	$0.0495	EA	Generic	—	2026-06-17
33342015915TAMSULOSIN HCL 0.4 MG CAPSULE	$0.0495	EA	Generic	—	2026-06-17
33342015944TAMSULOSIN HCL 0.4 MG CAPSULE	$0.0495	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain19 active DMFs17 inactive

17 active API suppliers hold Drug Master Files for this ingredient.

LEK PHARMACEUTICALS DDTAMSULOSIN HYDROCHLORIDE

DMF 173182004

ZYDUS LIFESCIENCES LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 176882004

SCINOPHARM TAIWAN LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 187172005

DIVIS LABORATORIES LTDTAMSULOSIN HYDROCHLORIDE

DMF 189712005

COHANCE LIFESCIENCES LTDTAMSULOSIN HYDROCHLORIDE

DMF 196472006

SYNTHON BVTAMSULOSIN HYDROCHLORIDE

DMF 200822006

WOCKHARDT LTDTAMSULOSIN HYDROCHLORIDE

DMF 200952006

QUIMICA SINTETICA SATAMSULOSIN HYDROCHLORIDE

DMF 210412007

SUN PHARMACEUTICAL INDUSTRIES LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 219002008

GENTHON BVTAMSULOSIN HYDROCHLORIDE

DMF 223892009

MEDICHEM SATAMSULOSIN HYDROCHLORIDE (MED-201750/E)

DMF 231452009

ALP PHARM BEIJING CO LTDTAMSULOSIN HYDROCHLORIDE

DMF 237412010

UNICHEM LABORATORIES LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 243742010

COHANCE LIFESCIENCES LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 286482014

MACLEODS PHARMACEUTICALS LTDTAMSULOSIN HYDROCHLORIDE MODIFIED RELEASE PELLETS 0.4 MG/ 275MG

DMF 304502016

MACLEODS PHARMACEUTICALS LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 358002021

SWATI SPENTOSE PRIVATE LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 369342022

VASUDHA PHARMA CHEM LTDTAMSULOSIN HYDROCHLORIDE USP

DMF 375422022

ANWITA DRUGS & CHEMICALS PVT LTDTAMSULOSIN HYDROCHLORIDE 0.2% SR PELLETS

DMF 417422025

ASTELLAS PHARMA INCInactiveTAMSULOSIN HYDROCHLORIDE

DMF 117611995

ASTELLAS IRELAND CO LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 138781998

DR REDDYS LABORATORIES LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 172472004

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveTAMSULOSIN HYDROCHLORIDE USP

DMF 178652004

TAI HENG INDUSTRY CO LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 180672005

CIPLA LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 181792005

NATCO PHARMA LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 183922005

ZENTIVA KSInactiveTAMSULOSIN HYDROCHLORIDE

DMF 181862005

MAPRIMED SAInactiveTAMSULOSIN HYDROCHLORIDE

DMF 182472005

ZAMBON SAInactiveTAMSULOSIN HYDROCHLORIDE

DMF 188892005

RAGACTIVES SLInactiveTAMSULOSIN HYDROCHLORIDE

DMF 198772006

PCASInactiveTAMSULOSIN HYDROCHLORIDE

DMF 202902007

GEDEON RICHTER PLCInactiveTAMSULOSIN HYDROCHLORIDE

DMF 202912007

HOVIONE FARMACIENCIA SAInactiveTAMSULOSIN HYDROCHLORIDE

DMF 218032008

FERMION OYInactiveTAMSULOSIN HYDROCHLORIDE

DMF 235952010

JIANGSU HENGRUI MEDICINE CO LTDInactiveTAMSULOSIN HYDROCHLORIDE USP, NON-STERILE, BULK SUBSTANCE

DMF 236952010

ZHEJIANG JINHUA CONBA BIO-PHARM CO LTDInactiveTAMSULOSIN HYDROCHLORIDE

DMF 301102015

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 27, 2017	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.4MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jan 20, 2017

No patent or exclusivity listings for this strength.